Not every private biopharmaceutical firm can be Moderna Therapeutics LLC, bringing in hundreds of millions of venture capital dollars in a single fundraising attempt, but startups in the hot immuno-oncology field – like Tioma Therapeutics Inc. and Arcus Biosciences Inc. – continue to raise large Series A and follow-on VC rounds.
Moderna already has accumulated enough money to match the record-breaking $450m venture capital round that it closed in January 2015,...